Literature DB >> 16758323

Polymorphism of apolipoproteine E in relation with Alzheimer and vascular dementia.

Zuzana Gdovinová1, Viera Habalová, Zuzana Novosadová.   

Abstract

1. The epsilon 4 allele of the apolipoprotein E gene increases the risk of late onset familial and sporadic Alzheimer disease. Relation of epsilon 4 allele of the apolipoprotein E gene to various types of dementia and the onset of dementia were analyzed in the present study. 2. The study comprised 139 patients (50 men and 89 women) with dementia, mean age 73.61 years (range 47-98). The diagnosis of dementia was made according to Diagnostic and Statistical Manual of Mental Disorders, and subtypes diagnoses were made according to NINCDS-ADRDA and NINDS-AIREN criteria. Minimental State Examination (MMSE) was used for the screening of dementia. Apolipoprotein E polymorphism was determined by the PCR-RFLP technique-polymerase chain reaction and subsequent digestion with specific restriction endonuclease. For statistical analyses chi-square test and the crude Gart s odds ratio (OR) and 95% confidence intervals (CI) were used. 3. From 139 dementia patients (MMSE < or =24 points) in 61 (45%) Alzheimer disease (AD) was present, in 44 patients (31%) vascular dementia (VD), and in 34 (24%) mixed dementia (MD) were revealed. In comparison with control group the presence of at least one ApoE-varepsilon4 allele was significantly higher only in the group with AD (p < 0.001), (OR=2.76; 95%: 1.42-5.36). The frequency of epsilon4 allele carriers was significantly overrepresented in AD group compared with VD (chi(2)=5.94; p=0.0148). Differences between AD and MD or VD and MD were not confirmed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758323     DOI: 10.1007/s10571-006-9043-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  15 in total

1.  Mortality differences by APOE genotype estimated from demographic synthesis.

Authors:  Douglas C Ewbank
Journal:  Genet Epidemiol       Date:  2002-02       Impact factor: 2.135

2.  Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

Authors:  K R Bales; T Verina; R C Dodel; Y Du; L Altstiel; M Bender; P Hyslop; E M Johnstone; S P Little; D J Cummins; P Piccardo; B Ghetti; S M Paul
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

3.  A simple and efficient method for apolipoprotein E genotype determination.

Authors:  J Chapman; J Estupiñan; A Asherov; L G Goldfarb
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

4.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  L Fratiglioni; L J Launer; K Andersen; M M Breteler; J R Copeland; J F Dartigues; A Lobo; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

5.  The association between APOE and dementia does not seem to be mediated by vascular factors.

Authors:  M Prince; S Lovestone; J Cervilla; S Joels; J Powell; C Russ; A Mann
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

Review 6.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

7.  NADPH-diaphorase activity in the spinal cord after ischemic injury and the effects of pretreatment with Ginkgo biloba extract (EGb 761).

Authors:  Eva Mechírová; Iveta Domoráková
Journal:  Acta Histochem       Date:  2002       Impact factor: 2.479

Review 8.  Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.

Authors:  W J Strittmatter; K H Weisgraber; M Goedert; A M Saunders; D Huang; E H Corder; L M Dong; R Jakes; M J Alberts; J R Gilbert
Journal:  Exp Neurol       Date:  1994-02       Impact factor: 5.330

9.  Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.

Authors:  T Lehtimäki; T Pirttilä; P D Mehta; H M Wisniewski; H Frey; T Nikkari
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

10.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  1 in total

1.  Hippocampal Neurodegenerative Pathology in Post-stroke Dementia Compared to Other Dementias and Aging Controls.

Authors:  Rufus O Akinyemi; Louise M Allan; Arthur Oakley; Rajesh N Kalaria
Journal:  Front Neurosci       Date:  2017-12-19       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.